Bill Deegan

Founder at Cellebration Life Sciences, Inc.

72 year

Finance

Health Technology

Profile

Bill Deegan is the founder of Cellebration Life Sciences, Inc. He was previously the Chief Financial Officer, Secretary & Treasurer at American Housing Income Trust, Inc.

Bill Deegan active positions

Companies	Position	Start
Cellebration Life Sciences, Inc. Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation.	Founder	-

All active positions of Bill Deegan

Former positions of Bill Deegan

Companies	Position	End
American Housing Income Trust, Inc. American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ.	Director of Finance/CFO	24/06/2015

See the detail of Bill Deegan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bill Deegan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
American Housing Income Trust, Inc. American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ.	Finance
Cellebration Life Sciences, Inc. Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation.	Health Technology